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Conclusions: We could observe a tendency of fewer SREs in TG com-
pared to CG. More patients will be needed to get statistically signiﬁcant 
differences according to treatment arms.
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Introduction: Euthanasia has taken its place again in discussion 
agenda after the legal arrangements permitting active euthanasia in the 
Netherlands and Belgium were made. Physicians’ views, especially of 
those working in the ﬁeld of oncology, are very important in revealing 
the views on euthanasia. Our study was conducted to show the ap-
proach of the pulmonologists heavily working in the ﬁeld of oncology 
in Turkey.
Materials and Methods: In our survey study, 110 physicians working 
in pulmonary medicine in Turkey were accessed, and the data were as-
sessed By SPSS program.
Results: The mean age of the pulmonologists participating in our study 
was 32.90±7.01 years, and 40.8 % of these stated not being against 
euthanasia. Of the participants, 22.7 % stated encountering “ wish 
for euthanasia”, and 46.7 % stated believing that euthanasia is being 
performed hiddenly though for bidden.
Conclusion: The views on euthanasia and patient rights of the physi-
cians attending terminal-stage patients are very important. The partici-
pating physicians frequently encountering “wish for euthanasia” and 
their extensive beliefs about that euthanasia is being performed hid-
denly shows this issue should absolutely be discussed in our country.
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Background: Previous studies have shown that antibacterial prophy-
laxis after cytotoxic chemotherapy reduces the incidence of febrile 
episode and infection. However the role of prophylactic antibacterial 
agents after chemotherapy remains controversial. The meaning of fe-
brile episode and infection is vague as outcome variable after cytotoxic 
chemotherapy, but pneumonia in lung cancer after cytotoxic chemo-
therapy can bring life-threatening consequences on patients.
The purpose of this study is to demonstrate the prevalence and risk 
factors of pneumonia after cytotoxic chemotherapy in advanced lung 
cancer patients.
Methods: 229 patients took cytotoxic chemotherapy in Seoul National 
University Hospital for advanced lung cancer progressed during a year 
2005, and 12 patients who took prophylactic antibiotics were excluded 
from this study. Therefore 217 patients were retrospectively analyzed.
Those patients, who had not taken chemotherapy or radiation therapy 
previously with ECOG performance status 0-2, stage III or IV NSCLCa 
and SCLCa, were eligible for this study. Pneumonia after chemo-
therapy was deﬁned as pneumonia which developed after ﬁrst cycle of 
ﬁrst line chemotherapy. Risk factors such as age, sex, ECOG perfor-
mance status, pathological diagnosis, stage of disease, smoking, COPD 
(FEV1/FVC less than 70%), tumor position and pneumonia history 
were analyzed.
Results: The mean age was 61 years (range, 31-85). The number of 
male patients were 171 (79%), and ECOG 2 patients were 40 (18%). 
COPD patients constituted 18% (40 patients) out of all the patients.
Pneumonia occurred in 10 patients (4%) out of 217 after cytotoxic che-
motherapy, and the occurrence rate was signiﬁcantly higher in COPD 
patients, compared to non-COPD patients (13% vs 3%, P=0.02), and 
also higher in patients with ECOG 2 compared to those with ECOG 
0~1 (10% vs 3%, P=0.09). One patient out of ten with pneumonia died 
from sepsis, the other one could not received further cytotoxic chemo-
therapy.
Twelve patients had taken antibacterial prophylaxis after pneumonia 
before chemotherapy, and a pneumonia developed in one patient (8%) 
after chemotherapy. Four patients hadn’t taken antibacterial prophy-
laxis after outbreak of pneumonia, and the one among 4 of them (25%) 
had developed into pneumonia.
Conclusions: This study demonstrated that the patients with COPD, 
deﬁned as FEV1/FVC less than 70% and the ones with poor perfor-
mance signiﬁcantly showed higher incidence of pneumonia.
A prospective study is required to verify the risk factors that affect in-
cidence of pneumonia after cytotoxic chemotherapy, and to clarify the 
effect of antibacterial prophylaxis on patients in high risk.
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Introduction: In 1980, Dewys WD et al. (Am J Med 1980;69:491-7) 
have demonstrated a high prevalence of malnutrition in cancer patients, 
including lung cancer. The aim of the present study was to re-evaluate, 
25 years later, the prevalence of malnutrition in a non selected popula-
tion of cancer patients and also the nutritional support to these patients.
Methods: A prospective one-day prevalence survey was carried out 
in 154 wards of private or public hospitals in 24 cities in France. 
Height, actual and usual body weight were systematically assessed 
in outpatients and inpatients who were present that day. Malnutrition 
was deﬁned as a BMI≤18.5 (for 18-74 aged patients) or BMI≤21 (for 
patients of 75 years or more) and/or a loss of body weight ≥ 10% from 
the beginning of the disease.
Results: 2,068 patients (1,189 men and 879 women) aged 59.3 ± 13.6 
years were evaluated and nutritional status was available in 1,903 
patients: 247 patients had lung cancer (72% of inpatients and 28% of 
outpatients); 1821 patients had head and neck, leukemia/lymphoma, 
colon/rectum, stomach, oesophagus, pancreas, breast, ovary/uterus, 
prostate cancer. Lung cancer was local in 9% of patients, loco-regional 
in 25% and metastatic in 66%. Within lung cancer patients, 89% of 
